Scientific Program - Saturday 11 May
| Saturday 11 May, 2019 | Sunday 12 May, 2019 |
| Saturday 11 April, 2019 | |
|
HALL A
|
|
| 09:00-10:30 Chairs: 09:00-09:15 09:15-09:30 09:30-09:45 09:45-10:00 10:00-10:15 10:15-10:30 |
Session 1 | Cardiovascular outcome in Diabetes Su Benjil, China, Mu Yiming, China and Antonio Ceriello, Italy Is the CVO in CVOT's applicable for the Asian population? Yes: Antonio Ceriello, Italy No: Li Guangwei, China Discussion Prevention of cardiac events in primary prevention: Should we use SGLT2 or glucosidase inhibitors? SGLT2: Itamar Raz, Israel Glucosidase Inhibitors: Liu Jianmin, China Discussion |
|
HALL B
|
|
|
09:00-10:30
Chairs: 09:00-09:15 09:15-09:30 09:30-09:45 09:45-10:30 |
Session 2 | Management of Glucolipid Metabolism
Gu Weiqiong, China, Jiao Kai, China and Luc Van Gaal, Belgium
Should we treat NASH by drugs of surgery? Yes: Luc Van Gaal, Belgium No: Qu Shen, China Discussion Omega-3 fatty acids in glucolipid matabolism: Wang Weiqing, China |
|
HALL C
|
|
|
09:00-10:30
Chairs: 09:00-09:15 09:15-09:30 09:30-09:45 09:45-10:00 10:00-10:15 10:15-10:30 |
Session 3 | Controversies of Antidiabetic Therapies
Liu Libin, China, Chen Bing, China and Eberhard Standl, Germany Should glucosidase inhibitors be the first drug in type 2 diabetic patients in Asia? Yes: Wang Weiqing, China No: Eberhard Standl, Germany Discussion Is SGLT2 a safe drug? Yes: Philip Home, UK No: Weng Jianping, China Discussion |
|
10:30-10:50
|
VISIT EXHIBITS & COFFEE BREAK
|
| 10:50-11:50 | INDUSTRY SPONSORED SYMPOSIA A-C |
| 11:50-12:00 | LUNCH BOX PICK UP |
| 12:00-13:00 | INDUSTRY SPONSORED SYMPOSIA D-F |
|
HALL A
|
|
|
13:00-14:30
Chairs: |
Session 4 | Focus on Basal Insulin: Initiation and combination
Zou Daijin, China and Wang Weiqing, China The insulin initiation perios is essential to reach metabolic control in patients with T2DM: Feng Bo, China The only GLP-1RA with basal insulin combination indication in China: Zou Dajin, China |
|
HALL B
|
|
|
13:00-14:30
Chairs: 13:00-13:15 13:15-13:30 13:30-13:45 13:45-14:00 14:00-14:15 14:15-14:30 |
Session 5 | Kidney Protection and Islet Transplantation
Chen Gang, China, Shan Zhongyan, China and Paolo Pozzilli, Italy Can nephropathy be reversed? Yes: Itamar Raz, Israel No: Zheng Hongting, China Discussion Has pancreatic islet transplantation failed clinical expectations? Yes: Paolo Pozzilli, Italy No: Zhu Dalong, China Discussion |
|
HALL C |
|
| 13:00-14:30 Chairs: 13:00-13:15 13:15-13:30 13:30-13:45 13:45-14:00 14:00-14:15 14:15-14:30 |
Session 6 | Controversies of Novel Antidiabetic Therapies Qin Fojas, China, Tang Xulei, China and Mia C. Fojas, Philippines Are bio similar insulins equal to originators? Yes: Philip Home, UK No: Li Yan, China Discussion Controversies in Diabetes in Asia China: Teng Weiping, China Rest of the World: Mia C. Fojas, Philippines Discussion |
|
14:30-15:30
|
|
| 15:30-15:45 | VISIT EXHIBITS & COFFEE BREAK |
|
PLENARY HALL
|
|
|
15:45-16:00
Chairs: |
OPENING CEREMONY
Wang Weiqing, China and Zhu Dalong, China Welcome from the Congress Co-Chairs: Ning Guang, China and Itamar Raz, Israel |
|
PLENARY HALL
|
|
|
16:00-18:00
Chairs 16:00-16:45 16:45-17:15 17:15-17:45 17:45-18:00 |
Welcome Session | Key Note Lectures
Ning Guang, China and Itamar Raz, Israel Synergism in health diabestes as a parable: Itamar Raz, Israel The new biology of beta cell failure in diabetes: Domenico Accili, USA AI – What exactly is it and how will it influence the Diabetes handling: Dov Moran, Israel Discussion |
